New Key Statistics Module, Z-Score and F-Score
SHSE:688266 Key Ratios
Market Cap ¥ M | 18,172.22 |
Enterprise Value ¥ M | 16,752.27 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 190.69 |
Price/Book | 11.60 |
Price/Sales | 44.72 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 407.00 |
EPS (TTM) ¥ | -0.88 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -73.18 |
EV-to-EBITDA | -73.18 |
PEG | -- |
Shares Outstanding M | 264.71 |
Net Margin (%) | -56.70 |
Operating Margin % | -72.50 |
Pre-tax Margin (%) | -62.83 |
Quick Ratio | 2.19 |
Current Ratio | 2.31 |
ROA % (ttm) | -7.79 |
ROE % (ttm) | -13.84 |
ROIC % (ttm) | -23.49 |
Dividend Yield % | -- |
Altman Z-Score | 6.68 |
SHSE:688266 Number of Guru Trades
SHSE:688266 Volume of Guru Trades
Gurus Latest Trades with SHSE:688266
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688266 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Suzhou Zelgen Biopharmaceuticals Co Ltd Insider Transactions
No Available Data